Hepatocyte growth factor and its receptor c-met in multiple myeloma

Blood

Volumn 88, Issue 10, 1996, Pages 3998-4004

  Börset, Magne ^a,b   Hjorth Hansen, Henrik ^a   Seidel, Carina ^a   Sundan, Anders ^a   Waage, Anders ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; MESSENGER RNA; RECEPTOR PROTEIN; SCATTER FACTOR;

ARTICLE; BIOASSAY; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MULTIPLE MYELOMA; MYELOMA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029825852     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.3998.bloodjournal88103998     Document Type: Article

References (52)

1. Kawano M, Yamamoto I, Iwato K, Tanaka H, Asaoku H, Tanabe O, Ishikawa H, Nobuyoshi M, Ohmoto Y, Hirai Y, Kuramoto A: Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma. Blood 73:1646, 1989
2. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T: Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332:83, 1988
3. Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M, Bataille R: Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73:517, 1989
4. Portier M, Rajzbaum G, Zhang XG, Attal M, Rusalen C, Wijdenes J. Mannoni P, Maraninchi D, Piechaczyk M, Bataille R, Klein B: In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma. Eur J Immunol 21:1759, 1991
5. Hata H, Xiao H, Petrucci MT, Woodliff J, Chang R, Epstein J: Interleukin-6 gene expression in multiple myeloma: A characteristic of immature tumor cells. Blood 81:3357, 1993
6. Børset M, Helseth E, Naume B, Waage A: Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation. Br J Haematol 85:446, 1993
7. Zarnegar R, Michalopoulos GK: The many faces of hepatocyte growth factor: From hepatopoiesis to hematopoiesis. J Cell Biol 129:1177, 1995
8. Sato T, Hakeda Y, Yamaguchi Y, Mano H, Tezuka K, Matsumoto K, Nakamura T, Mori Y, Yoshizawa K, Sumitani K, Kodama H, Kumegawa M: Hepatocyte growth factor is involved in formation of osteoclast-like cells mediated by clonal stromal cells (MC3T3-G2/PA6). J Cell Physiol 164:197, 1995
9. Fuller K, Owens J, Chambers TJ: The effect of hepatocyte growth factor on the behaviour of osteoclasts. Biochem Biophys Res Commun 212:334, 1995
10. Grano M, Galimi F, Zambonin G, Colucci S, Cottone E, Zambonin Zallone A, Comoglio PM: Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc Natl Acad Sci USA 93:7644, 1996
11. Nakamura T, Nawa K, Ichihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122:1450, 1984
12. Kan M, Zhang GH, Zarnegar R, Michalopoulos G, Myoken Y, McKeehan WL, Stevens JI: Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE. Biochem Biophys Res Commun 174:331, 1991
13. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119:629, 1992
14. Otonkoski T, Beattie GM, Rubin JS, Lopez AD, Baird A, Hayek A: Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes 43:947, 1994
15. Kawaida K, Matsumoto K, Shimazu H, Nakamura T: Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 91:4357, 1994
16. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T: Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem 268:21212, 1993
17. Rosen EM, Goldberg ID, Kacinski BM, Buckholz T, Vinter DW: Smooth muscle releases an epithelial cell scatter factor which binds to heparin. In Vitro Cell Dev Biol 25:163, 1989
18. Stoker M, Gherardi E, Perryman M, Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327:239, 1987
19. Nakamura S, Gohda E, Matsunaga T, Yamamoto I, Minowada J: Production of hepatocyte growth factor by human haematopoietic cell lines. Cytokine 6:285, 1994
20. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802, 1991
21. Galimi F, Bagnara GP, Bonsi L, Cottone E, Follenzi A, Simeone A, Comoglio PM: Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors. J Cell Biol 127:1743, 1994
22. Kmiecik TE, Keller JR, Rosen E, Vande Woude GF: Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells. Blood 80:2454, 1992
23. Jucker M, Gunther A, Gradl G, Fonatsch C, Krueger G, Diehl V, Tesch H: The Met/hepalocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma. Leuk Res 18:7, 1994
24. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P, Comoglio PM: Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6:1997, 1991
25. Delaney B, Koh WS, Yang KH, Strom SC, Kaminski NE: Hepatocyte growth factor enhances B-cell activity. Life Sci 53:PL89, 1993
26. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, Vande Woude GF: Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311:29, 1984
27. Natali PG, Nicotra MR, Di Renzo MF, Prat M, Bigotti A, Cavaliere R, Comoglio PM: Expression of the c-Met/HGF receptor in human melanocytic neoplasms: Demonstration of the relationship to malignant melanoma tumour progression. Br J Cancer 68:746, 1993
28. Di Renzo MF, Olivero M, Katsaros D, Crepaldi T, Gaglia P, Zola P, Sismondi P, Comoglio PM: Overexpression of the Met/HGF receptor in ovarian cancer. Int J Cancer 58:658, 1994
29. Rong S, Jeffers M, Resau JH, Tsarfaty I, Oskarsson M, Vande Woude GF: Met expression and sarcoma tumorigenicity. Cancer Res 53:5355, 1993
30. Di Renzo MF, Olivero M, Ferro S, Prat M, Bongarzone I, Pilotti S, Belfiore A, Costantino A, Vigneri R, Pierotti MA, Comoglio PM: Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 7:2549, 1992
31. Ferracini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini P, Cremona O, Campanacci M, Comoglio PM: The Met/ HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 10:739, 1995
32. Ebert M, Yokoyama M, Friess H, Buchler MW, Korc M: Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 54:5775, 1994
33. Tsao MS, Zhu H, Giaid A, Viallet J, Nakamura T, Park M: Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ 4:571, 1993
34. Tsarfaty I, Rong S, Resau JH, Rulong S, da Silva PP, Vande Woude GF: The Met proto-oncogene mesenchymal to epithelial cell conversion. Science 263:98, 1994
35. Rong S, Bodescot M, Blair D, Dunn J, Nakamura T, Mizuno K, Park M, Chan A, Aaronson S, Vande Woude GF: Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol 12:5152, 1992
36. Bellusci S, Moens G, Gaudino G, Comoglio P, Nakamura T, Thiery JP, Jouanneau J: Creation of an hepatocyte growth factor/ scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9:1091, 1994
37. Børset M, Lien E, Espevik T, Helseth E, Waage A, Sundan A: Concomitant expression of hepatocyte growth factor/scatter factor and its receptor c-Met in human myeloma cell lines. J Biol Chem (in press)
38. Ridley RC, Xiao H, Hata H, Woodliff J, Epstein J, Sanderson RD: Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood 81:767, 1993
39. Funderud S, Erikstein B, Asheim HC, Nustad K, Stokke T, Blomhoff HK, Holte H, Smeland EB: Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation. Eur J Immunol 20:201, 1990
40. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440, 1989
41. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude G: Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci USA 84:6379, 1987
42. Gough NM: Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Anal Biochem 173:93, 1988
43. Gearing AJ, Bird CR, Bristow A, Poole S, Thorpe R: A simple sensitive bioassay for interleukin-1 which is unresponsive to 10(3) U/ml of interleukin-2. J Immunol Methods 99:7, 1987
44. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348, 1986
45. Mundy GR, Raisz LG, Cooper RA, Schlechter GP, Salmon SE: Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med 291:1041, 1974
46. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T: IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297, 1990
47. Gowen M, Mundy GR: Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro. J Immunol 136:2478, 1986
48. Bataille R, Chappard D, Klein B: The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma. Int J Clin Lab Res 21:283, 1992
49. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S, Setoguchi M, Tachikawa T, Shin S, Arima T, Daikuhara Y: Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 13:1, 1991
50. Nakamura S, Gohda E, Matsuo Y, Yamamoto I, Minowada J: Significant amount of hepatocyte growth factor detected in blood and bone marrow plasma of leukaemia patients. Br J Haematol 87:640, 1994
51. Park M, Dean M, Cooper CS, Schmidt M, O'Brien SJ, Blair DG, Vande Woude GF: Mechanism of met oncogene activation. Cell 45:895, 1986
52. Weimar IS, Muller EJ, de Gast GC, Nakamura T, de Jung D, Gerritsen WR: Hepatocyte growth factor stimulates adhesion/ invasion of c-Met positive lymphoma cells. Blood 86:184a, 1995 (abstr, suppl 1)